A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis.
Zeng YS, Peng J, Gao XF, Tian D, Zhan W, Liu J, Hu XJ, Huang S, Tian ST, Qiu L, Liang AL, Wang FY, Dong RH, Guang B, Yang T.
Zeng YS, et al. Among authors: liang al.
Eur J Pharmacol. 2022 Dec 15;937:175381. doi: 10.1016/j.ejphar.2022.175381. Epub 2022 Nov 8.
Eur J Pharmacol. 2022.
PMID: 36368417